NetworkNewsBreaks

WednesdayAug 12, 2020 12:25 pm

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Achieves Critical Milestone Through Award of Key Patent

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of a key U.S. patent entitled "Sample Preparation Devices and Methods." According to the update, the new patent (U.S. 10,710,082) brings the company's intellectual property ("IP") estate up to a total of 25 issued patents. "We have many customers worldwide who routinely use our ‘PCT’ Micro-Pestle consumable in their research studies. These include Professor Phil Robinson and his team at the Children's Medical Research Institute in Australia (processing…

Continue Reading

WednesdayAug 12, 2020 12:08 pm

NetworkNewsBreaks – FWD Pharma 2020 to Shine Spotlight on Impactful Digital Trends in Today’s Shifting Landscape

Lincoln Health Network’s second annual FWD Pharma Conference is set to draw an engaging lineup of marketing and brand practitioners from leading organizations and shine the spotlight on biotech and life-science strategies in a complex digital world. Slated to be held Aug. 31-Sept. 1, 2020, the event promises to amplify attendees’ digital transformation of commercial operations and market access through omnichannel engagements, campaign analytics and marketing automation. FWD Pharma 2020 will feature keynotes, interactive panels, case studies, hands-on workshops, and peer-to-peer learning opportunities. A diverse group of marketing and brand practitioners from leading life-sciences organizations will share successful strategies to…

Continue Reading

WednesdayAug 12, 2020 11:52 am

NetworkNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Expands Channel Partner Distribution to Include Leading ‘DSD’ Provider – Mahaska

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused waters and CBD-infused products, today announced that its entire line of beverage offerings, including flavored waters, will be carried by Mahaska, a leading direct-store-deliver (“DSD”) provider in some of the major markets in the Midwest. “We are excited to announce the addition of Mahaska to our growing list of channel partners. As a best in class provider, the partnership opens an important regional market for us in our pursuit to be a national lifestyle brand across all major retail channels,” Richard Wright, president and…

Continue Reading

WednesdayAug 12, 2020 11:29 am

NetworkNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Posts Record Revenues in July, Reaching $2.3M

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, has released monthly performance data for July. Those numbers — $2.3 million in total sales from cannabis products — exceeded company projections and mark a record sales performance for the company. The report attributes much of this record-breaking growth to its improved positioning in the California cannabis market among partners and distributors. “It would be easy to lose perspective at this point because we exceeded our own expectations by such a wide margin in July,” said Cannabis Strategic Ventures CEO Simon Yu in the press release. “That…

Continue Reading

WednesdayAug 12, 2020 11:05 am

NetworkNewsBreaks – Tongji Healthcare Group, Inc. (TONJ) Enters Agreement to Acquire West of Hudson Group Inc. ‘WOHG’ – Sole Owner of ‘The Clubhouse’

Tongji Healthcare Group (OTC: TONJ), today announced its entry into a share exchange agreement to acquire West of Hudson Group Inc. (“WOHG”), the sole and complete owner of “The Clubhouse.” According to the update, The Clubhouse is a collection of content creation houses located in the scenic mansions of Southern California that houses some of the most prominent and widely followed social media influencers, together carrying an estimated base in excess of 70 million followers. Closing of the acquisition is subject to customary conditions, including the pending completion of the target’s financial audit process, expected in September 2020. “The Clubhouse…

Continue Reading

WednesdayAug 12, 2020 10:29 am

NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q2 Revenue, Overview of Key Company Highlights and Development

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released a business update, including financial numbers and corporate achievements for the second quarter ended June 30, 2020. Highlights of the report include the company’s announcement of two Remote Patient Monitoring (“RPM”) agreements in the United States as well as an agreement with Williams Medical, which allowed Dario to enter the United Kingdom. In addition, the company reported Q2 revenues of $1.79 million, a 7.2% sequential increase from Q1 2020. "The COVID-19 pandemic has accelerated our ongoing transformation to a business-to-business-to-consumer (B2B2C) digital therapeutics leader," said Dario CEO Erez…

Continue Reading

WednesdayAug 12, 2020 10:09 am

NetworkNewsBreaks – Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) Featured in Mizuho Securities Research Report

Satsuma Pharmaceuticals (NASDAQ: STSA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Satsuma reported 2Q20 earnings that were close to Street expectations with a net loss of ($11.3M) (vs. Mizuho at ($12.7M) and consensus at ($12.8M)), and EPS of ($0.65) (vs. Mizuho at ($0.69) and consensus at ($0.73)). More importantly for a clinical-stage company such as Satsuma is the progress they are making with their pipeline, and all parts of the STS101 program appear on track. The company recently announced completion of the treatment phase of the Phase 3 EMERGE trial…

Continue Reading

TuesdayAug 11, 2020 2:51 pm

NetworkNewsBreaks – The Very Good Food Company Inc. (CSE: VERY) (FSE: 0SI) Achieves Next Critical Step in Scaling Ecommerce Business

The Very Good Food Company (CSE: VERY) (FSE: 0SI) today announced its entry into an agreement with three third party logistics providers ("3PL") to increase shipping speed and reduce associated costs for its ecommerce store orders. The company also completed improvements to its Victoria facility to increase throughput and position it for a near-term ramp up in production. "The 3PL hubs were the next critical step in building our ecommerce business to be truly scalable,” The Very Good Food Company CEO, Mitchell Scott, stated in the news release. “Previously, all shipping was centralized out of our Victoria facility, which delayed…

Continue Reading

TuesdayAug 11, 2020 1:19 pm

NetworkNewsBreaks – Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Featured in Mizuho Securities Research Report

Biohaven Pharmaceutical Holding Company (NYSE: BHVN) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We are updating our Biohaven model after 2Q20 earnings, accounting for the results and the recently announced financing agreement with Royalty Pharma (RPRX; Not Covered) and term loan with Sixth Street to support Nurtec ODT's ongoing launch and the development of zavegepant. We believe these agreements provide attractive forms of financing that obviate the near-term need for additional capital raise, while allowing Biohaven to compete in the migraine market. Nurtec's uptake continues to impress us, and we…

Continue Reading

TuesdayAug 11, 2020 1:11 pm

NetworkNewsBreaks – Revance Therapeutics, Inc. (NASDAQ: RVNC) Featured in Mizuho Securities Research Report

Revance Therapeutics (NASDAQ: RVNC) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We are assuming coverage of Revance Therapeutics with a Buy rating and $32 PT (from $35). We see the aesthetics market as an attractive one over the long term, despite the significant challenges and uncertainty it is facing given the ongoing COVID-19 pandemic. We forecast a slow launch for both Daxi and Revance’s RHA Collection dermal filler line, but expect enough positive progress, along with positive data from therapeutic indications, for continued stock appreciation. Our estimates are guided by…

Continue Reading